PNC
SNY icon

Park National Corp’s Sanofi SNY Stock Holding History

Park National Corp’s Portfolio SNY Stock Details SNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-4,213
Closed -$203K – 386
2026
Q1 		$203K Sell
4,213
-319
-7% -$14.9K 0.01% 316
2025
Q4 		$220K Buy
+4,532
New +$225K 0.01% 297

Other funds holding SNY

DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
QCM
QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
FBT
First Bank & Trust Brookings, South Dakota $680M AUM 25.36% 1-Year Est. Return
FB
Fulton Bank Lancaster, Pennsylvania $3.27B AUM 17.38% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
PCM
Palouse Capital Management Spokane, Washington $160M AUM 36.15% 1-Year Est. Return
PAS
Park Avenue Securities New York $16B AUM 26.77% 1-Year Est. Return
AAM
Augustine Asset Management Jacksonville, Florida $494M AUM 76.22% 1-Year Est. Return

Park National Corp's SNY Position: Q2 2026 in Review

Park National Corp sold out of Sanofi (SNY) in Q2 2026, closing a stake of 4,213 shares — an estimated $203K sold.

Park National Corp first reported a position in SNY in Q4 2025 and held it in 2 quarters. The position peaked at $220K in Q4 2025. 96 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Park National Corp reported no remaining Sanofi position as of Q2 2026 after selling out during the quarter.
  • Park National Corp sold 4,213 Sanofi shares in Q2 2026, an estimated $203K.
  • Park National Corp first reported a position in Sanofi in Q4 2025 and held it in 2 quarters.
  • Park National Corp's Sanofi position peaked at $220K in Q4 2025.
  • 96 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Park National Corp's 13F filing for Q2 2026, filed 15 Jul 2026.